Cognitive ERPs are related to ApoE allelic variation in mildly cognitively impaired patients

Neuroscience Letters

Volumn 382, Issue 3, 2005, Pages 346-351

  Reinvang, Ivar ^a,b   Espeseth, Thomas ^a,b   Gjerstad, Leif ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ApoE; Event related potentials; Mild cognitive impairment; N1; N2

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; AMPLITUDE MODULATION; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EVENT RELATED POTENTIAL; FEMALE; GENE DOSAGE; GENETIC VARIABILITY; HUMAN; MALE; MEMORY DISORDER; PRIORITY JOURNAL;

AGED; ALLELES; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; VARIATION (GENETICS);

EID: 19544381371     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.03.024     Document Type: Article

References (35)

1. G.E. Alexander, K. Chen, P. Pietrini, S.I. Rapoport, and E.M. Reiman Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies Am. J. Psychiatry 159 2002 738 745
2. H. Amieva, L. Letenneur, J.F. Dartigues, I. Rouch-Leroyer, C. Sourgen, F. D'Alchee-Biree, M. Dib, P. Barberger-Gateau, J.M. Orgogozo, and C. Fabrigoule Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study Dement. Geriatr. Cogn. Disord. 18 2004 87 93
3. G. Bartzokis Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease Neurobiol. Aging 25 2004 5 18
4. M.W. Bondi, D.P. Salmon, D. Galasko, R.G. Thomas, and L.J. Thal Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease Psychol. Aging 14 1999 295 303
5. S.Y. Bookheimer, M.H. Strojwas, M.S. Cohen, A.M. Saunders, M.A. Pericak-Vance, J.C. Mazziotta, and G.W. Small Patterns of brain activation in people at risk for Alzheimer's disease N. Engl. J. Med. 343 2000 450 456
6. P. Bretsky, J.M. Guralnik, L. Launer, M. Albert, and T.E. Seeman The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging Neurology 60 2003 1077 1081
7. C.R. Brumback, K.A. Low, G. Gratton, and M. Fabiani Sensory ERPs predict differences in working memory span and fluid intelligence NeuroReport 15 2004 373 376
8. T.W. Budd, R.J. Barry, E. Gordon, C. Rennie, and P.T. Michie Decrement of the N1 auditory event-related potential with stimulus repetition: habituation vs refractoriness Int. J. Psychophysiol. 31 1998 51 68
9. M.D. Comerchero, and J. Polich P3a, P3b from typical auditory and visual stimuli Clin. Neurophysiol. 110 1999 24 30
10. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
11. C. DeCarli, B.L. Miller, G.E. Swan, T. Reed, P.A. Wolf, and D. Carmelli Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study Arch. Neurol. 58 2001 643 647
12. C. DeCarli, D. Mungas, D. Harvey, B. Reed, M. Weiner, H. Chui, and W.C. Jagust Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia Neurology 63 2004 220 227
13. S. Engelborghs, B. Dermaut, J. Goeman, J. Saerens, P. Marien, B.A. Pickut, M. Van den Broeck, S. Serneels, M. Cruts, C. Van Broeckhoven, and P.P. De Deyn Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects J. Neurol. Neurosurg. Psychiatry 74 2003 1148 1151
14. E.J. Golob, J.K. Johnson, and A. Starr Auditory event-related potentials during target detection are abnormal in mild cognitive impairment Clin. Neurophysiol. 113 2002 151 161
15. J. Green, and A.I. Levey Event-related potential changes in groups at increased risk for Alzheimer disease Arch. Neurol. 56 1999 1398 1403
16. P.M. Greenwood, and R. Parasuraman Normal genetic variation, genetics and aging Behav. Cogn. Neurosci. Rev. 2 2003 278 306
17. A. Heyman G. Fillenbaum F. Nash Consortium to establish a registry for Alzheimer's disease: the CERAD experience Neurology 49 Suppl. 3 1997
18. S.Y. Hill, J. Locke, N. Zezza, B. Kaplan, K. Neiswanger, S.R. Steinhauer, G. Wipprecht, and J. Xu Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism Biol. Psychiatry 43 1998 40 51
19. M. Hyde The N1 response and its applications Audiol. Neurootol. 2 1997 281 307
20. V.S. Mattay, and T.E. Goldberg Imaging genetic influences in human brain function Curr. Opin. Neurobiol. 14 2004 239 247
21. R. Näätänen, and T. Picton The N1 wave of the human electric and magnetic responses to sound: a review and analysis of the component structure Psychophysiology 24 1987 375 425
22. E. Pekkonen, I.P. Jääskeläinen, M. Hietanen, M. Huotilainen, R. Näätänen, R.J. Ilmoniemi, and T. Erkinjuntti Impaired preconscious auditory processing and cognitive functions in Alzheimer's disease Clin. Neurophysiol. 110 1999 1942 1947
23. R.C. Petersen Mild cognitive impairment as a diagnostic entity J. Intern. Med. 256 2004 183 194
24. R.C. Petersen, G.E. Smith, R.J. Ivnik, E.G. Tangalos, D.J. Schaid, S.N. Thibodeau, E. Kokmen, S.C. Waring, and L.T. Kurland Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals J. Am. Med. Assoc. 273 1995 1274 1278
25. J. Polich P300 in clinical applications E. Niedermeyer F. Lopes da Silva Electroencephalography: Basic Principles, Clinical Applications and Related Fields 4th ed. 1999 Urban & Schwarzenberg Baltimore-Munich 1073 1091
26. E.M. Reiman, R.J. Caselli, K. Chen, G.E. Alexander, D. Bandy, and J. Frost Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 98 2001 3334 3339
27. E.M. Reiman, K. Chen, G. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc. Natl. Acad. Sci. U.S.A. 101 2004 284 289
28. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, S. Minoshima, S.N. Thibodeau, and D. Osborne Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E N. Engl. J. Med. 334 1996 752 758
29. I. Reinvang, K. Sundet, A.J. Lundervold, S. Andersson, H. Nordby, and A.-K. Solbakk ERP (P3) and aging - the role of attention I. Reinvang M.W. Greenlee M. Herrmann The Cognitive Neuroscience of Individual Differences 2003 BIS-Verlag Oldenburg 279 288
30. H.V. Semlitch, P. Anderer, P. Schuster, and O. Presslitsch A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP Psychophysiology 23 1986 696 703
31. J. Sinkkonen, and M. Tervaniemi Towards optimal recording and analysis of the mismatch negativity Audiol. Neurootol. 5 3/4 2000 235 246
32. S. Tervo, M. Kivipelto, T. Hanninen, M. Vanhanen, M. Hallikainen, A. Mannermaa, and H. Soininen Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects Dement. Geriatr. Cogn. Disord. 17 2004 196 203
33. C.E. van Beijsterveldt, and G.C. van Baal Twin and family studies of the human electroencephalogram: a review and a meta-analysis Biol. Psychol. 61 2002 111 138
34. G. Winterer, M. Smolka, J. Samochowiec, C. Mulert, M. Ziller, R. Mahlberg, Y. Wuebben, J. Gallinat, H. Rommelspacher, W.M. Herrman, and T. Sander Association analysis of GABAAbeta2 and gamma2 gene polymorphisms with event-related prefrontal activity in man Hum. Genet. 107 2000 513 518
35. Y.W. Yu, S.J. Tsai, K.H. Yang, C.H. Lin, M.C. Chen, and C.J. Hong Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine Neuropsychobiology 43 2001 79 82